GLPG Galapagos N.V. Operating Profitability

Graphic logo of Galapagos (GLPG)

Geopolitical instability in Europe creates risks for the logistics and research of Galapagos NV (GLPG). The company is offsetting this by redistributing capital toward CAR-T therapy and immunology. The operating margin indicator visualizes the efficiency of the current model, where the 44.10 metric determines the status of the profitability parameter. Long-term contracts with global partners and stable royalties ensure the holding's financial stability.

GLPG: glpg.com Operating Margin 07/04/2022 - 05/08/2026

Metric breakdowns and analytics for glpg.com (GLPG)

- share price and consensus valuation forecast:
Initial company analysis:Galapagos Genomics
Core merchandise of Galapagos NV

The implementation of robotic platforms for small molecule screening at Galapagos NV minimizes operating expenses, directly increasing the share of core operating profit in every dollar of revenue. By analyzing the operating margin trend, an investor assesses resource management efficiency before accounting for financial obligations and taxes, which allows for the identification of business stability phases or the risk of stagnating returns.

Competitor analysis for Galapagos NV

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|anipharmaceuticals.com - Operating Profit Rate|Operating Sales Margin MNKD|AMPH: Operating Profit Rate|Operating Profitability pacira.com (PCRX)|Operating Margin ARS Pharma (SPRY)|Theravance Biopharma - Operating Sales Margin|Operating Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Operating Sales Margin|Operating Return on Sales Tectonic Therapeutic|TNXP: Operating Margin|SXT China (SXTC) - Operating Margin|Operating Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Profitability of Operations|Operating Profitability Invizyne (EXOZ)|ORMP - Operating Return on Sales|Operating Margin ENTX (Entera Bio)|Operating Profitability Margin MindWalk Therapeutics|ABVC: Operating Sales Margin|CPIX - Operating Margin|QNTM (Quantum BioPharma) - Operating Sales Margin|Operating Profit Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Operating Margin|Operating Margin ranitherapeutics.com|Operating Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Return on Sales by Operating Profit|lexariabioscience.com - Operating Sales Margin|Operating Margin Pulmatrix Inc PULM|Pheton Holdings - Operating Margin|Operating Profit Margin APM|Lyra Therapeutics, Inc. (LYRA) - Operating Profitability|Operating Return on Sales Impact BioMedical, Inc. (IBO)|Operating Profitability TNF Pharma|YCBD: Operating Profit Rate|Operating Margin PRFX|CYTO - Operating Return on Sales|Operating Profitability Lipella LIPO|Operating Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Operating Profitability|Procaps (PROC) - Operating Sales Margin|PTPI: Operating Margin|Qilian International (QLI) - Operating Margin|Operating Profitability Acelyrin, Inc.|Operating Margin TFF Pharmaceuticals, Inc.